Nyxoah (Nyxoah) Accounts Payable : $3.46 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Nyxoah Accounts Payable?

Nyxoah's Accounts Payable for the quarter that ended in Mar. 2024 was $3.46 Mil.

Nyxoah's quarterly Accounts Payable increased from Sep. 2023 ($2.29 Mil) to Dec. 2023 ($4.47 Mil) but then declined from Dec. 2023 ($4.47 Mil) to Mar. 2024 ($3.46 Mil).

Nyxoah's annual Accounts Payable declined from Dec. 2021 ($2.71 Mil) to Dec. 2022 ($1.98 Mil) but then increased from Dec. 2022 ($1.98 Mil) to Dec. 2023 ($4.47 Mil).

Nyxoah Accounts Payable Historical Data

The historical data trend for Nyxoah's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nyxoah Accounts Payable Chart

Nyxoah Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

1.30

0.99

2.71

1.98

4.47

Nyxoah Quarterly Data
	Dec17	Dec18	Jun19	Dec19	Mar20	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															1.56	2.88	2.29	4.47	3.46

Nyxoah Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Nyxoah Accounts Payable Related Terms

Thank you for viewing the detailed overview of Nyxoah's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Nyxoah (Nyxoah) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nyxoah SA (NAS:NYXH) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

5YI:Germany NYXH:Belgium

Address

Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435

Website

https://www.nyxoah.com

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.